Skip to main content
Clinical Trials/NL-OMON47430
NL-OMON47430CompletedNot Applicable

Assessment of chronic renal allograft dysfunction with MRI: a pilot study - ACRADYS

niversitair Medisch Centrum Utrecht0 sites50 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
50

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • Group A (n=15):
  • Patients have undergone at least one kidney transplantation procedure;Patients are 18 year or older;Patients are currently suspect for CAD at the time of inclusion (CAD is defined as a clinical diagnosis characterized by deterioration of kidney function in any way (e.g. increase in SCr, new proteinuria) that demands further diagnostic evaluation; Kidney biopsy is performed according to the existing guidelines for clinical practice just prior to or shortly after the MRI-scan has been performed (time in between the events < 2 weeks) ;Time between NTx and inclusion must be at least 6 months,Patients volunteer to participate and are capable and prepared to sign an informed consent.;Group B (n=20):
  • Volunteers have undergone at least one kidney transplantation procedure; Volunteers are 18 year or older; volunteers have a well-functioning allograft and are not showing any clinical signs of allograft dysfunction; Time between NTx and inclusion is at least 3 months; Volunteers are capable and prepared to sign an informed consent;Group C1 (n=15 - x):
  • Volunteers have donated a kidney to someone that is included in group A or B; Volunteers are 18 year or older; Volunteers are not altruistic kidney donor; Volunteers are not diagnosed with any renal disease; Volunteers are prepared to give a blood sample for analysis of the SCr; Volunteers are capable and prepared to sign an informed consent.;Group C2 (n=x):
  • Volunteers are 18 year or older; Volunteers are not diagnosed with any renal disease; Volunteers are prepared to give a blood sample for analysis of the SCr; Volunteers are capable and prepared to sign an informed consent; Volunteers can be sex- and age matched within a range of 5 years to patients in group A/B1 (who are not already matched to their donor). Part of the volunteer data will consist of data from volunteers who are already scanned for another study (ReMARK, METC NL45144.041.13, 13/402) under the same conditions with the same scan protocol.

Exclusion Criteria

  • Volunteers with contra-indications for MRI (like a pacemaker, an internal prosthesis or claustrophobia); Refusal of volunteers to be informed of chance findings possibly relevant to their health; Pregnancy.

Investigators

Sponsor
niversitair Medisch Centrum Utrecht

Similar Trials